SCHEMBL11033647

SCHEMBL11033647

C=CCn1cnnc1-c1cncc(N)c1

nearest known ligand 0.32

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32680041 0.74 POLB (0.47) SMN1; SMN2ALDH1A1
SCHEMBL29653558 0.72 — —
SCHEMBL30988452 0.69 MAP3K5 (0.42) —
SCHEMBL20472009 0.66 ASIC3 (0.37) RAB9ASMN1; SMN2ALDH1A1
SCHEMBL7205591 0.62 — —
SCHEMBL5779690 0.62 — —
SCHEMBL8763485 0.61 ADORA2B (0.32) —
SCHEMBL18912024 0.61 IRAK4 (0.34) RAB9AALDH1A1
SCHEMBL4607798 0.61 SMN1; SMN2 (0.51) SMN1; SMN2ALDH1A1
SCHEMBL27364397 0.60 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4497814-A 2-(Pyridinyl)-1,2,4-triazolo[1,5-a]pyrimidines and derivatives useful in increasing cardiac contractility SCHERING CORPORATION (US) 1985-02-05 — — US disclosed
Send feedback